Genmab A/S Cash Flow Quality Index
Genmab A/S cash flow quality index. Genmab A/S (GMAB) has a Cash Flow Quality Index of 1.11x as of September 2025. Operating cash flow of Dkr536.00 Million exceeds net income of Dkr482.00 Million, indicating high earnings quality where cash backs reported profits. See GMAB financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Genmab A/S (2013–2024)
Cash flow quality index of Genmab A/S from 2013 to 2024. Historical Cash Flow Quality Index for Genmab A/S across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Genmab A/S (GMAB) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Genmab A/S Cash Flow Quality Index by Year (2013–2024)
Genmab A/S cash flow quality index by year from 2013 to 2024. Year-by-year earnings quality comparison for Genmab A/S. For the full cash flow conversion analysis, see Genmab A/S cash conversion from operations.
| Year | Quality Index | Operating CF (DKK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | Dkr7.77 Billion | Dkr7.84 Billion | ▼ -24.3% |
| 2023 | 1.31x | Dkr7.38 Billion | Dkr5.64 Billion | ▲ +135.4% |
| 2022 | 0.56x | Dkr3.91 Billion | Dkr7.04 Billion | ▼ -0.6% |
| 2021 | 0.56x | Dkr2.23 Billion | Dkr3.98 Billion | ▼ -48.7% |
| 2020 | 1.09x | Dkr6.43 Billion | Dkr5.90 Billion | ▲ +134.9% |
| 2019 | 0.46x | Dkr1.33 Billion | Dkr2.86 Billion | ▼ -26.3% |
| 2018 | 0.63x | Dkr1.01 Billion | Dkr1.61 Billion | ▼ -57.9% |
| 2017 | 1.49x | Dkr1.59 Billion | Dkr1.06 Billion | ▲ +415.2% |
| 2016 | 0.29x | Dkr327.72 Million | Dkr1.13 Billion | ▼ -29.5% |
| 2015 | 0.41x | Dkr311.45 Million | Dkr757.53 Million | ▼ -7.9% |
| 2014 | 0.45x | Dkr132.67 Million | Dkr297.35 Million | ▲ +137.5% |
| 2013 | -1.19x | Dkr-128.00 Million | Dkr107.64 Million | — |